{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:57:12Z","timestamp":1790186232767,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,31]]},"DOI":"10.7759\/cureus.42768","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T01:13:54Z","timestamp":1690852434000},"source":"Crossref","is-referenced-by-count":8,"title":["Comparing Current Therapeutic Modalities of Androgenic Alopecia: A Literature Review of Clinical Trials"],"prefix":"10.7759","author":[{"given":"Parth S","family":"Bajoria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prathma Anandbhai","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph Kingsford","family":"Rohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charu","family":"Tibrewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naisargi Shrikant","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth Kamal","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyansh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17738","article-title":"Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial","volume":"36","author":"Piraccini BM","year":"2022","unstructured":"Piraccini BM, Blume-Peytavi U, Scarci F, et al.. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. J Eur Acad Dermatol Venereol. 2022, 36:286-94. 10.1111\/jdv.17738","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1501893","article-title":"Effectiveness and safety of botulinum toxin type A in the treatment of androgenetic alopecia","volume":"2020","author":"Zhou Y","year":"2020","unstructured":"Zhou Y, Yu S, Zhao J, Feng X, Zhang M, Zhao Z. Effectiveness and safety of botulinum toxin type A in the treatment of androgenetic alopecia. Biomed Res Int. 2020, 2020:1501893. 10.1155\/2020\/1501893","journal-title":"Biomed Res Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01880-x","article-title":"Androgenetic alopecia: therapy update","volume":"83","author":"Devjani S","year":"2023","unstructured":"Devjani S, Ezemma O, Kelley KJ, Stratton E, Senna M. Androgenetic alopecia: therapy update. Drugs. 2023, 83:701-15. 10.1007\/s40265-023-01880-x","journal-title":"Drugs"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/cells12060951","article-title":"Human stem cell use in androgenetic alopecia: a systematic review","volume":"12","author":"Krefft-Trzciniecka K","year":"2023","unstructured":"Krefft-Trzciniecka K, Pi\u0119towska Z, Nowicka D, Szepietowski JC. Human stem cell use in androgenetic alopecia: a systematic review. Cells. 2023, 12:951. 10.3390\/cells12060951","journal-title":"Cells"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.88a.20014","article-title":"Male and female pattern hair loss: treatable and worth treating","volume":"88","author":"Tamashunas NL","year":"2021","unstructured":"Tamashunas NL, Bergfeld WF. Male and female pattern hair loss: treatable and worth treating. Cleve Clin J Med. 2021, 88:173-82. 10.3949\/ccjm.88a.20014","journal-title":"Cleve Clin J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_262_17","article-title":"Genetic and molecular aspects of androgenetic alopecia","volume":"84","author":"Martinez-Jacobo L","year":"2018","unstructured":"Martinez-Jacobo L, Villarreal-Villarreal CD, Ortiz-L\u00f3pez R, Ocampo-Candiani J, Rojas-Mart\u00ednez A. Genetic and molecular aspects of androgenetic alopecia. Indian J Dermatol Venereol Leprol. 2018, 84:263-8. 10.4103\/ijdvl.IJDVL_262_17","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2004.05.001","article-title":"Different gene expression profile observed in dermal papilla cells related to androgenic alopecia by DNA macroarray analysis","volume":"36","author":"Midorikawa T","year":"2004","unstructured":"Midorikawa T, Chikazawa T, Yoshino T, Takada K, Arase S. Different gene expression profile observed in dermal papilla cells related to androgenic alopecia by DNA macroarray analysis. J Dermatol Sci. 2004, 36:25-32. 10.1016\/j.jdermsci.2004.05.001","journal-title":"J Dermatol Sci"},{"key":"ref8","article-title":"Physiology, hair","author":"Hoover E","year":"2023","unstructured":"Hoover E, Alhajj M, Flores JL. Physiology, hair. StatPearls. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000481141","article-title":"An open-label randomized multicenter study assessing the noninferiority of a caffeine-based topical liquid 0.2% versus minoxidil 5% solution in male androgenetic alopecia","volume":"30","author":"Dhurat R","year":"2018","unstructured":"Dhurat R, Chitallia J, May TW, et al.. An open-label randomized multicenter study assessing the noninferiority of a caffeine-based topical liquid 0.2% versus minoxidil 5% solution in male androgenetic alopecia. Skin Pharmacol Physiol. 2018, 30:298-305. 10.1159\/000481141","journal-title":"Skin Pharmacol Physiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.188652","article-title":"Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: a randomized controlled open-label, evaluator-blinded study","volume":"83","author":"Shanshanwal SJ","year":"2017","unstructured":"Shanshanwal SJ, Dhurat RS. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: a randomized controlled open-label, evaluator-blinded study. Indian J Dermatol Venereol Leprol. 2017, 83:47-54. 10.4103\/0378-6323.188652","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7162.865","article-title":"Male pattern androgenetic alopecia","volume":"317","author":"Sinclair R","year":"1998","unstructured":"Sinclair R. Male pattern androgenetic alopecia. BMJ. 1998, 317:865. 10.1136\/bmj.317.7162.865","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.116730","article-title":"Androgenetic alopecia: an update","volume":"79","author":"Kaliyadan F","year":"2013","unstructured":"Kaliyadan F, Nambiar A, Vijayaraghavan S. Androgenetic alopecia: an update. Indian J Dermatol Venereol Leprol. 2013, 79:613-25. 10.4103\/0378-6323.116730","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2014.07.006","article-title":"Histologic features of alopecias-part I: nonscarring alopecias","volume":"106","author":"Bern\u00e1rdez C","year":"2015","unstructured":"Bern\u00e1rdez C, Molina-Ruiz AM, Requena L. Histologic features of alopecias-part I: nonscarring alopecias. Actas Dermosifiliogr. 2015, 106:158-67. 10.1016\/j.ad.2014.07.006","journal-title":"Actas Dermosifiliogr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5070\/D3247040910","article-title":"Platelet-rich plasma for androgenic alopecia treatment: a comprehensive review","volume":"24","author":"Girijala RL","year":"2018","unstructured":"Girijala RL, Riahi RR, Cohen PR. Platelet-rich plasma for androgenic alopecia treatment: a comprehensive review. Dermatol Online J. 2018, 24:13030-8. 10.5070\/D3247040910","journal-title":"Dermatol Online J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4065\/80.10.1316","article-title":"Psychological effect, pathophysiology, and management of androgenetic alopecia in men","volume":"80","author":"Stough D","year":"2005","unstructured":"Stough D, Stenn K, Haber R, Parsley WM, Vogel JE, Whiting DA, Washenik K. Psychological effect, pathophysiology, and management of androgenetic alopecia in men. Mayo Clin Proc. 2005, 80:1316-22. 10.4065\/80.10.1316","journal-title":"Mayo Clin Proc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2023.02.006","article-title":"[Translated article] Trichoscopy: an update","volume":"114","author":"Fern\u00e1ndez-Domper L","year":"2023","unstructured":"Fern\u00e1ndez-Domper L, Ballesteros-Redondo M, Va\u00f1\u00f3-Galv\u00e1n S. [Translated article] Trichoscopy: an update. Actas Dermosifiliogr. 2023, 114:T327-33. 10.1016\/j.ad.2023.02.006","journal-title":"Actas Dermosifiliogr"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2077.178536","article-title":"Classifications of patterned hair loss: a review","volume":"9","author":"Gupta M","year":"2016","unstructured":"Gupta M, Mysore V. Classifications of patterned hair loss: a review. J Cutan Aesthet Surg. 2016, 9:3-12. 10.4103\/0974-2077.178536","journal-title":"J Cutan Aesthet Surg"},{"key":"ref18","article-title":"Endotext","author":"Asfour L","year":"2000","unstructured":"Asfour L, Cranwell W, Sinclair R. Endotext. Male androgenetic alopecia. Feingold KR, Anawalt B, Blackman MR, et al. (ed): MDText.com, Inc., South Dartmouth (MA); 2000."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.15570\/actaapa.2016.12","article-title":"Efficacy and safety of 5% minoxidil topical foam in male pattern hair loss treatment and patient satisfaction","volume":"25","author":"Hasanzadeh H","year":"2016","unstructured":"Hasanzadeh H, Nasrollahi SA, Halavati N, Saberi M, Firooz A. Efficacy and safety of 5% minoxidil topical foam in male pattern hair loss treatment and patient satisfaction. Acta Dermatovenerol Alp Pannonica Adriat. 2016, 25:41-4. 10.15570\/actaapa.2016.12","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_1156_16","article-title":"The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia","volume":"84","author":"Faghihi G","year":"2018","unstructured":"Faghihi G, Mozafarpoor S, Asilian A, et al.. The effectiveness of adding low-level light therapy to minoxidil 5% solution in the treatment of patients with androgenetic alopecia. Indian J Dermatol Venereol Leprol. 2018, 84:547-53. 10.4103\/ijdvl.IJDVL_1156_16","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186516","article-title":"Comparative evaluation of the clinical efficacy of PRP-therapy, minoxidil, and their combination with immunohistochemical study of the dynamics of cell proliferation in the treatment of men with androgenetic alopecia","volume":"21","author":"Pakhomova EE","year":"2020","unstructured":"Pakhomova EE, Smirnova IO. Comparative evaluation of the clinical efficacy of PRP-therapy, minoxidil, and their combination with immunohistochemical study of the dynamics of cell proliferation in the treatment of men with androgenetic alopecia. Int J Mol Sci. 2020, 21:6516. 10.3390\/ijms21186516","journal-title":"Int J Mol Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13399","article-title":"Similar response patterns to topical minoxidil foam 5% in frontal and vertex scalp of men with androgenetic alopecia: a microarray analysis","volume":"172","author":"Mirmirani P","year":"2015","unstructured":"Mirmirani P, Consolo M, Oyetakin-White P, Baron E, Leahy P, Karnik P. Similar response patterns to topical minoxidil foam 5% in frontal and vertex scalp of men with androgenetic alopecia: a microarray analysis. Br J Dermatol. 2015, 172:1555-61. 10.1111\/bjd.13399","journal-title":"Br J Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S43481","article-title":"Preparation and evaluation of a multimodal minoxidil microemulsion versus minoxidil alone in the treatment of androgenic alopecia of mixed etiology: a pilot study","volume":"7","author":"Sakr FM","year":"2013","unstructured":"Sakr FM, Gado AM, Mohammed HR, Adam AN. Preparation and evaluation of a multimodal minoxidil microemulsion versus minoxidil alone in the treatment of androgenic alopecia of mixed etiology: a pilot study. Drug Des Devel Ther. 2013, 7:413-23. 10.2147\/DDDT.S43481","journal-title":"Drug Des Devel Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/srt.12827","article-title":"Placebo-controlled dose-effect studies with topical minoxidil 2% or 5% in male-patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol","volume":"26","author":"Van Neste D","year":"2020","unstructured":"Van Neste D. Placebo-controlled dose-effect studies with topical minoxidil 2% or 5% in male-patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol. Skin Res Technol. 2020, 26:542-57. 10.1111\/srt.12827","journal-title":"Skin Res Technol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3609","article-title":"Platelet-rich plasma for androgenetic alopecia treatment: a randomized placebo-controlled pilot study","volume":"100","author":"Gressenberger P","year":"2020","unstructured":"Gressenberger P, Pregartner G, Gary T, Wolf P, Kopera D. Platelet-rich plasma for androgenetic alopecia treatment: a randomized placebo-controlled pilot study. Acta Derm Venereol. 2020, 100:1-7. 10.2340\/00015555-3609","journal-title":"Acta Derm Venereol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_589_18","article-title":"Comparison of efficacy of platelet-rich plasma therapy with or without topical 5% minoxidil in male-type baldness: a randomized, double-blind placebo control trial","volume":"86","author":"Singh SK","year":"2020","unstructured":"Singh SK, Kumar V, Rai T. Comparison of efficacy of platelet-rich plasma therapy with or without topical 5% minoxidil in male-type baldness: a randomized, double-blind placebo control trial. Indian J Dermatol Venereol Leprol. 2020, 86:150-7. 10.4103\/ijdvl.IJDVL_589_18","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114517","article-title":"Platelet lysate promotes hair growth: in vitro and in vivo mechanism and randomized, controlled trial","volume":"161","author":"Guan Q","year":"2023","unstructured":"Guan Q, Guo ZH, Dai DM, et al.. Platelet lysate promotes hair growth: in vitro and in vivo mechanism and randomized, controlled trial. Biomed Pharmacother. 2023, 161:114517. 10.1016\/j.biopha.2023.114517","journal-title":"Biomed Pharmacother"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-013-0060-6","article-title":"Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study","volume":"15","author":"Jimenez JJ","year":"2014","unstructured":"Jimenez JJ, Wikramanayake TC, Bergfeld W, Hordinsky M, Hickman JG, Hamblin MR, Schachner LA. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol. 2014, 15:115-27. 10.1007\/s40257-013-0060-6","journal-title":"Am J Clin Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-7-103","article-title":"\"Cold\" X5 Hairlaser\u2122 used to treat male androgenic alopecia and hair growth: an uncontrolled pilot study","volume":"7","author":"Blum K","year":"2014","unstructured":"Blum K, Han D, Madigan MA, Lohmann R, Braverman ER. \"Cold\" X5 Hairlaser\u2122 used to treat male androgenic alopecia and hair growth: an uncontrolled pilot study. BMC Res Notes. 2014, 7:103. 10.1186\/1756-0500-7-103","journal-title":"BMC Res Notes"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.18433\/jpps31456","article-title":"Efficacy of cetirizine 1% versus minoxidil 5% topical solution in the treatment of male alopecia: a randomized, single-blind controlled study","volume":"24","author":"Hossein Mostafa D","year":"2021","unstructured":"Hossein Mostafa D, Samadi A, Niknam S, Nasrollahi SA, Guishard A, Firooz A. Efficacy of cetirizine 1% versus minoxidil 5% topical solution in the treatment of male alopecia: a randomized, single-blind controlled study. J Pharm Pharm Sci. 2021, 24:137-266. 10.18433\/jpps31456","journal-title":"J Pharm Pharm Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.19-0410","article-title":"A randomized, double-blind, vehicle-controlled clinical study of hair regeneration using adipose-derived stem cell constituent extract in androgenetic alopecia","volume":"9","author":"Tak YJ","year":"2020","unstructured":"Tak YJ, Lee SY, Cho AR, Kim YS. A randomized, double-blind, vehicle-controlled clinical study of hair regeneration using adipose-derived stem cell constituent extract in androgenetic alopecia. Stem Cells Transl Med. 2020, 9:839-49. 10.1002\/sctm.19-0410","journal-title":"Stem Cells Transl Med"},{"key":"ref32","article-title":"A proprietary herbal extract against hair loss in androgenetic alopecia and telogen effluvium: a placebo-controlled, single-blind, clinical-instrumental study","volume":"27","author":"Pekmezci E","year":"2018","unstructured":"Pekmezci E, D\u00fcndar C, T\u00fcrko\u011flu M. A proprietary herbal extract against hair loss in androgenetic alopecia and telogen effluvium: a placebo-controlled, single-blind, clinical-instrumental study. Acta Dermatovenerol Alp Pannonica Adriat. 2018, 27:51-7.","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1089\/jmf.2017.0016","article-title":"Annurca apple nutraceutical formulation enhances keratin expression in a human model of skin and promotes hair growth and tropism in a randomized clinical trial","volume":"21","author":"Tenore GC","year":"2018","unstructured":"Tenore GC, Caruso D, Buonomo G, et al.. Annurca apple nutraceutical formulation enhances keratin expression in a human model of skin and promotes hair growth and tropism in a randomized clinical trial. J Med Food. 2018, 21:90-103. 10.1089\/jmf.2017.0016","journal-title":"J Med Food"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14537","article-title":"Treatment options for androgenetic alopecia: efficacy, side effects, compliance, financial considerations, and ethics","volume":"20","author":"Nestor MS","year":"2021","unstructured":"Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Treatment options for androgenetic alopecia: efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021, 20:3759-81. 10.1111\/jocd.14537","journal-title":"J Cosmet Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/176256-comparing-current-therapeutic-modalities-of-androgenic-alopecia-a-literature-review-of-clinical-trials","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:03:19Z","timestamp":1707508999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/176256-comparing-current-therapeutic-modalities-of-androgenic-alopecia-a-literature-review-of-clinical-trials"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,31]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.42768","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,31]]}}}